Study finds abortion bans restrict access to standard miscarriage care medication
By
Shefali Luthra
3d ago· 6 min readenNews
100/100
Golden Brown
Bagelometer↗
Sesame, salt, and substance. A flagship bake.
Score100TypenewsSentimentnegative
Summary
A new national study finds that abortion bans, particularly those restricting abortion at or before 6 weeks of pregnancy, are negatively impacting miscarriage care. Patients in these states are less likely to receive the standard two-drug regimen (mifepristone and misoprostol) used to manage miscarriages, which is the same medication protocol used for abortions. This is the first national analysis quantifying how abortion restrictions affect people experiencing pregnancy loss.
Key quotes
· 2 pulledIn states that banned abortion at or before 6 weeks of pregnancy, patients were less likely to be given the appropriate medication to facilitate their miscarriages: a two-drug regimen of mifepristone and misoprostol that is identical to the one used in abortions.
The research is the first national analysis to quantify how abortion restrictions affect people losing their pregnancies.
The research is the first national analysis to quantify how abortion restrictions affect people losing their pregnancies.
